The ecosystem breakfast on the theme: " Need to know early if your oncology/IO drug candidate has a good chance of success?" took place yesterday with a speech by Valérie Castellani, Scientific Director of the company Oncofactory, member of the ERBC group.
She presented the platform (AVI-PDX) which is based on a technology using patient-derived tumor models implanted in avian embryos. She demonstrated the ability of this model to provide rapid predictive data on the efficacy of anticancer therapies in just a few days.
Its activity also integrates large-scale molecular analyses and 3D imaging techniques, while enabling patient stratification and the discovery of biomarkers, which promote more personalized therapeutic approaches.
To learn more, his PPT presentation is available below:
See the presentation:
Comentários